{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:28:56Z","timestamp":1780622936005,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/MB\/01\/ICGC\/2009"],"award-info":[{"award-number":["BT\/MB\/01\/ICGC\/2009"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Smokeless tobacco associated Gingivobuccal squamous cell carcinoma (GB-SCC) is a major public health problem but available oral cancer cell lines are mostly from smoking associated tongue SCC raising the need for pertinent GB-SCC cell line models. As part of the International Cancer Genome Consortium (ICGC) Project, 4 novel cell lines, namely, Indian Tata Memorial Centre Oral Cancer (ITOC) \u221201 to \u221204 were established and characterized with conventional methods, karyotyping, ultrastructure, <jats:italic>in vivo<\/jats:italic> tumourigenicity, Whole exome sequencing (WES) and RNA sequencing. These hyperploid cell lines form xenografts in mice and show metabolically active and necrotic areas on fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging. WES of ITOC cell lines recapitulate the genomic tumor profile of ICGC GB-SCC database. We further identified smokeless tobacco associated genetic alterations (<jats:italic>PCLO, FAT3<\/jats:italic> and <jats:italic>SYNE2<\/jats:italic>) and oncogenic <jats:italic>PIK3CA<\/jats:italic> mutation in GB-SCC cell lines. Transcriptome profiling identified deregulation of pathways commonly altered in cancer and down-regulation of arachidonic acid metabolism pathway, implying its possible role in GB-SCC. Clinical application of high throughput sequencing data depends on relevant cell line models to validate potential targets. Extensively characterized, these oral SCC cell lines are particularly suited for mechanistic studies and pre-clinical drug development for smokeless tobacco associated oral cancer.<\/jats:p>","DOI":"10.1038\/s41598-019-44143-0","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T10:07:20Z","timestamp":1559642840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Establishment and genomic characterization of gingivobuccal carcinoma cell lines with smokeless tobacco associated genetic alterations and oncogenic PIK3CA mutation"],"prefix":"10.1038","volume":"9","author":[{"given":"Kshama","family":"Pansare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Gardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayee","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerana","family":"Dange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Previn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Gera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradnya","family":"Kowtal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-8282","authenticated-orcid":false,"given":"Rajiv","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"44143_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45, 309\u2013316 (2009).","journal-title":"Oral Oncol."},{"key":"44143_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.oraloncology.2008.04.007","volume":"45","author":"R Walvekar","year":"2009","unstructured":"Walvekar, R. et al. Squamous cell carcinoma of the gingivobuccal complex: Predictors of locoregional failure in stage III\u2013IV cancers. Oral Oncol. 45, 135\u2013140 (2009).","journal-title":"Oral Oncol."},{"key":"44143_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A. et al. Global Cancer Statistics. CA Cancer J Clin. 61, 69\u201390 (2011).","journal-title":"CA Cancer J Clin."},{"key":"44143_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3322\/caac.21384","volume":"67","author":"K Shield","year":"2017","unstructured":"Shield, K. et al. The Global Incidence of Lip, Oral Cavity, and Pharyngeal Cancers by Subsite in 2012. CA Cancer J Clin. 67, 51\u201364 (2017).","journal-title":"CA Cancer J Clin."},{"key":"44143_CR5","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1007\/s00405-016-4051-0","volume":"273","author":"S Nair","year":"2016","unstructured":"Nair, S. et al. Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities. Eur Arch OtoRhinoLaryngol. 273, 3921\u20138 (2016).","journal-title":"Eur Arch OtoRhinoLaryngol."},{"key":"44143_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3873","volume":"4","author":"India Project Team of ICGC","year":"2013","unstructured":"India Project Team of ICGC. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun. 4, 2873 (2013).","journal-title":"Nat Commun."},{"key":"44143_CR7","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1245\/s10434-010-1174-1","volume":"17","author":"CT Liao","year":"2010","unstructured":"Liao, C. T. et al. Tongue and buccal mucosa carcinoma: is there a difference in outcome? Ann Surg Oncol. 17, 2984\u201391 (2010).","journal-title":"Ann Surg Oncol."},{"key":"44143_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00432-006-0111-y","volume":"132","author":"KM Sathyan","year":"2006","unstructured":"Sathyan, K. M. et al. Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma. J Cancer Res Clin Oncol. 132, 601\u20139 (2006).","journal-title":"J Cancer Res Clin Oncol."},{"key":"44143_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/CBM-2009-0604","volume":"5","author":"S Shukla","year":"2009","unstructured":"Shukla, S. et al. Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomarkers. 5, 127\u201335 (2009).","journal-title":"Cancer Biomarkers."},{"key":"44143_CR10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.aad7363","volume":"350","author":"L Alexandrov","year":"2015","unstructured":"Alexandrov, L. Understanding the origins of human cancer. Science. 350, 1175 (2015).","journal-title":"Science."},{"key":"44143_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0027-5107(03)00013-7","volume":"526","author":"G Pfeifer","year":"2003","unstructured":"Pfeifer, G. & Hainaut, P. On the origin of G->\u2009T transversions in lung cancer. Mutat Res. 526, 39\u201343 (2003).","journal-title":"Mutat Res."},{"key":"44143_CR12","first-page":"1133","volume":"15","author":"K Kannan","year":"1999","unstructured":"Kannan, K. et al. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India. Int J Oncol. 15, 1133\u20136 (1999).","journal-title":"Int J Oncol."},{"key":"44143_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 517, 576\u2013582 (2015).","journal-title":"Nature."},{"key":"44143_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbcan.2008.12.004","volume":"1795","author":"WCG Van Staveren","year":"2009","unstructured":"Van Staveren, W. C. G. et al. Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta Rev Cancer. 1795, 92\u2013103 (2009).","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"44143_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35043102","volume":"1","author":"JR Masters","year":"2000","unstructured":"Masters, J. R. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol. 1, 233 (2000).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"44143_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep44700","volume":"7","author":"B Lohberger","year":"2017","unstructured":"Lohberger, B. et al. Liegl-Atzwanger, Establishment of a novel cellular model for myxofibrosarcoma heterogeneity. Sci. Rep. 7, 44700 (2017).","journal-title":"Sci. Rep."},{"key":"44143_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1328-z","volume":"15","author":"G Miserocchi","year":"2017","unstructured":"Miserocchi, G. et al. Management and potentialities of primary cancer cultures in preclinical and translational studies. J Transl Med. 15, 229 (2017).","journal-title":"J Transl Med."},{"key":"44143_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/hed.20478","volume":"29","author":"C Lin","year":"2007","unstructured":"Lin, C. et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck. 29, 163\u201388 (2007).","journal-title":"Head Neck."},{"key":"44143_CR19","first-page":"453","volume":"19","author":"S Hamid","year":"2007","unstructured":"Hamid, S. et al. Establishment and characterization of Asian oral cancer cell lines as in vitro models to study a disease prevalent in Asia. Int J Mol Med. 19, 453\u2013460 (2007).","journal-title":"Int J Mol Med."},{"key":"44143_CR20","doi-asserted-by":"publisher","first-page":"27802","DOI":"10.18632\/oncotarget.8533","volume":"7","author":"M Fadlullah","year":"2016","unstructured":"Fadlullah, M. et al. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies. Oncotarget. 7, 27802 (2016).","journal-title":"Oncotarget."},{"key":"44143_CR21","doi-asserted-by":"publisher","first-page":"C3","DOI":"10.1152\/ajpcell.00281.2013","volume":"306","author":"K Shah","year":"2014","unstructured":"Shah, K., McCormack, C. & Bradbury, N. Do you know the sex of your cells? Am J Physiol Cell Physiol. 306, C3\u2013C18 (2014).","journal-title":"Am J Physiol Cell Physiol."},{"key":"44143_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep13249","volume":"5","author":"Y Yoshino","year":"2015","unstructured":"Yoshino, Y. & Ishioka, C. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Sci Rep. 5, 13249 (2015).","journal-title":"Sci Rep."},{"key":"44143_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pneurobio.2006.07.006","volume":"79","author":"E Beurel","year":"2006","unstructured":"Beurel, E. & Jope, R. The paradoxical pro-and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol. 79, 173\u201389 (2006).","journal-title":"Prog Neurobiol."},{"key":"44143_CR24","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"J Fridman","year":"2003","unstructured":"Fridman, J. & Lowe, S. Control of apoptosis by p53. Oncogene. 22, 9030\u201340 (2003).","journal-title":"Oncogene."},{"key":"44143_CR25","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/cdd.2011.30","volume":"18","author":"M Olsson","year":"2011","unstructured":"Olsson, M. & Zhivotovsky, B. Caspases and cancer. Cell Death Differ. 18, 1441\u20139 (2011).","journal-title":"Cell Death Differ."},{"key":"44143_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cytogfr.2010.06.003","volume":"21","author":"A Singh","year":"2010","unstructured":"Singh, A. & Morris, R. The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev. 21, 299\u2013313 (2010).","journal-title":"Cytokine Growth Factor Rev."},{"key":"44143_CR27","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/onc.2012.263","volume":"32","author":"M Eissmann","year":"2013","unstructured":"Eissmann, M. et al. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms. Oncogene. 32, 2586\u201391 (2013).","journal-title":"Oncogene."},{"key":"44143_CR28","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.oraloncology.2008.01.018","volume":"44","author":"Z Shao","year":"2008","unstructured":"Shao, Z., Zhang, W., Chen, X. & Shang, Z. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. Oral Oncol. 44, 1110\u20137 (2008).","journal-title":"Oral Oncol."},{"key":"44143_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.11613\/BM.2011.036","volume":"21","author":"A Del Prete","year":"2011","unstructured":"Del Prete, A. et al. Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb). 21, 264\u201375 (2011).","journal-title":"Biochem Med (Zagreb)."},{"key":"44143_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/emm.2005.48","volume":"37","author":"E Lee","year":"2005","unstructured":"Lee, E. et al. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med. 37, 379\u201390 (2005).","journal-title":"Exp Mol Med."},{"key":"44143_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3353\/omp.9.133","volume":"9","author":"A Fujisawa","year":"2004","unstructured":"Fujisawa, A., Ikeda, H., Tobita, T. & Inokuchi, T. Establishment and characterization of human oral squamous cell carcinoma cell lines. Oral Med Pathol. 9, 133\u2013139 (2004).","journal-title":"Oral Med Pathol."},{"key":"44143_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.oraloncology.2006.07.007","volume":"43","author":"S Kok","year":"2007","unstructured":"Kok, S. et al. Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma. Oral Oncol. 43, 639\u201347 (2007).","journal-title":"Oral Oncol."},{"key":"44143_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0278-2391(90)90436-6","volume":"48","author":"D Wong","year":"1990","unstructured":"Wong, D., Chang, K., Chen, C. & Chang, R. Characterization of Two New Cell Lines Derived From Oral Cavity Human Squamous Cell Carcinomas-OC1 and OC2. J Oral Maxillofac Surg. 48, 385\u2013390 (1990).","journal-title":"J Oral Maxillofac Surg."},{"key":"44143_CR34","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1158\/1078-0432.CCR-11-0690","volume":"17","author":"M Zhao","year":"2011","unstructured":"Zhao, M. et al. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res. 17, 7248\u201364 (2011).","journal-title":"Clin Cancer Res."},{"key":"44143_CR35","first-page":"1151","volume":"20","author":"G Lee","year":"2002","unstructured":"Lee, G. et al. Characterization of novel cell lines established from three human oral squamous cell carcinomas. Int J Oncol. 20, 1151\u20139 (2002).","journal-title":"Int J Oncol."},{"key":"44143_CR36","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3892\/or.2017.5990","volume":"38","author":"H Liu","year":"2017","unstructured":"Liu, H. et al. Myeloid zinc finger 1 protein is a key transcription stimulating factor of PYROXD2 promoter. Oncol Rep. 38, 3245\u20133253 (2017).","journal-title":"Oncol Rep."},{"key":"44143_CR37","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/hep.26540","volume":"58","author":"S Cleary","year":"2013","unstructured":"Cleary, S. et al. Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology. 58, 1693\u2013702 (2013).","journal-title":"Hepatology."},{"key":"44143_CR38","first-page":"3794","volume":"8","author":"J Zhu","year":"2015","unstructured":"Zhu, J., Ding, H., Wang, X. & Lu, Q. PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c. Int J Clin Exp Pathol. 8, 3794\u2013802 (2015).","journal-title":"Int J Clin Exp Pathol."},{"key":"44143_CR39","first-page":"175","volume":"35","author":"B Keam","year":"2015","unstructured":"Keam, B. et al. In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer. Anticancer Res. 35, 175\u201382 (2015).","journal-title":"Anticancer Res."},{"key":"44143_CR40","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1200\/JCO.2017.72.7107","volume":"36","author":"D Juric","year":"2018","unstructured":"Juric, D. et al. Phosphatidylinositol 3-Kinase \u03b1\u2013Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study. J Clin Oncol. 36, 1291\u20131299 (2018).","journal-title":"J Clin Oncol."},{"key":"44143_CR41","doi-asserted-by":"publisher","first-page":"e101670","DOI":"10.1371\/journal.pone.0101670","volume":"9","author":"W Reinhold","year":"2014","unstructured":"Reinhold, W. et al. NCI-60 whole exome sequencing and pharmacological CellMiner analyses. PLoS One. 9, e101670 (2014).","journal-title":"PLoS One."},{"key":"44143_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-55","volume":"5","author":"A Ertel","year":"2006","unstructured":"Ertel, A., Verghese, A., Byers, S., Ochs, M. & Tozeren, A. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer. 5, 55 (2006).","journal-title":"Mol Cancer."},{"key":"44143_CR43","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/onc.2017.4","volume":"36","author":"M Kim","year":"2017","unstructured":"Kim, M. et al. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug. Oncogene. 36, 5199\u20135211 (2017).","journal-title":"Oncogene."},{"key":"44143_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jop.12485","volume":"46","author":"C Nguyen","year":"2017","unstructured":"Nguyen, C. et al. LAMC2 is a predictive marker for the malignant progression of leukoplakia. J Oral Pathol & Med. 46, 223\u201331 (2017).","journal-title":"J Oral Pathol & Med."},{"key":"44143_CR45","doi-asserted-by":"publisher","first-page":"e0146530","DOI":"10.1371\/journal.pone.0146530","volume":"11","author":"Y He","year":"2016","unstructured":"He, Y. et al. Large scale transcriptomics analysis suggests over-expression of BGH3, MMP9 and PDIA3 in oral squamous cell carcinoma. PLoS One. 11, e0146530 (2016).","journal-title":"PLoS One."},{"key":"44143_CR46","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1038\/ncomms6835","volume":"5","author":"NK Biswas","year":"2014","unstructured":"Biswas, N. K., Das, S., Maitra, A., Sarin, R. & Majumder, P. P. Somatic mutations in arachidonic acid metabolism pathway genes enhance oral cancer post-treatment disease-free survival. Nature Commun. 5, 5835 (2014).","journal-title":"Nature Commun."},{"key":"44143_CR47","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1073\/pnas.0510146103","volume":"13","author":"Y Liu","year":"2006","unstructured":"Liu, Y. & Bodmer, W. F. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. PNAS. 13, 976\u2013981 (2006).","journal-title":"PNAS."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44143-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44143-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44143-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:13:59Z","timestamp":1671272039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44143-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44143"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44143-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"18 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8272"}}